Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ASND

Ascendis Pharma

$28.48

0.49 (1.75%)

04:55
07/20/17
07/20
04:55
07/20/17
04:55
Conference/Events
Ascendis Pharma management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

Tuesday
ASND

Ascendis Pharma

$27.79

-0.3 (-1.07%)

08:13
07/18/17
07/18
08:13
07/18/17
08:13
Conference/Events
Ascendis Pharma management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

Over a week ago
ASND

Ascendis Pharma

$28.09

0.09 (0.32%)

13:45
07/17/17
07/17
13:45
07/17/17
13:45
Conference/Events
Ascendis Pharma has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

ASND

Ascendis Pharma

$28.09

0.09 (0.32%)

04:55
07/17/17
07/17
04:55
07/17/17
04:55
Conference/Events
Ascendis Pharma has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

ASND

Ascendis Pharma

$27.99

-0.41 (-1.44%)

08:05
07/12/17
07/12
08:05
07/12/17
08:05
Conference/Events
Ascendis Pharma has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

Over a month ago
ASND

Ascendis Pharma

$25.41

-0.64 (-2.46%)

16:04
05/23/17
05/23
16:04
05/23/17
16:04
Hot Stocks
Ascendis Pharma CEO says 'on track' with development programs »

"We are on track…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 06

    Jun

ASND

Ascendis Pharma

$25.41

-0.64 (-2.46%)

16:03
05/23/17
05/23
16:03
05/23/17
16:03
Earnings
Ascendis Pharma reports Q1 EPS EUR (0.78) vs. EUR (0.82) a year ago »

Reports Q1 revenue EUR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 06

    Jun

INTU

Intuit

$127.16

1.78 (1.42%)

, HEI

Heico

$74.25

-0.07 (-0.09%)

12:44
05/23/17
05/23
12:44
05/23/17
12:44
Earnings
Notable companies reporting after market close »

Notable companies…

INTU

Intuit

$127.16

1.78 (1.42%)

HEI

Heico

$74.25

-0.07 (-0.09%)

OOMA

Ooma

$11.73

0.08 (0.69%)

ASND

Ascendis Pharma

$26.05

-1.45 (-5.27%)

BRS

Bristow Group

$14.25

0.14 (0.99%)

VSAT

ViaSat

$63.85

-0.3 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 24

    May

  • 06

    Jun

  • 14

    Jun

MEOH

Methanex

$43.50

1.1 (2.59%)

, PTC

PTC

$53.32

-0.5 (-0.93%)

10:25
05/11/17
05/11
10:25
05/11/17
10:25
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

MEOH

Methanex

$43.50

1.1 (2.59%)

PTC

PTC

$53.32

-0.5 (-0.93%)

PXD

Pioneer Natural

$171.02

-0.25 (-0.15%)

ASND

Ascendis Pharma

$27.69

0.04 (0.14%)

CTRL

Control4

$18.07

0.13 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 17

    May

  • 25

    May

  • 06

    Jun

ASND

Ascendis Pharma

$27.69

0.04 (0.14%)

06:18
05/11/17
05/11
06:18
05/11/17
06:18
Initiation
Ascendis Pharma initiated at JPMorgan »

Ascendis Pharma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.